A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

Author: Kobrinsky B.   Joseph S.   Muggia F.   Liebes L.   Beric A.   Malankar A.   Ivy P.   Hochster H.  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.72, Iss.5, 2013-11, pp. : 1073-1078

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content